Skip to main content

Peer Review reports

From: Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care

Original Submission
28 Dec 2021 Submitted Original manuscript
24 May 2022 Reviewed Reviewer Report - Kirsty Loudon
21 Jun 2022 Author responded Author comments - Sarah Alderson
Resubmission - Version 2
21 Jun 2022 Submitted Manuscript version 2
24 Jun 2022 Editorially accepted
8 Jul 2022 Article published 10.1186/s13063-022-06492-6

You can find further information about peer review here.

Back to article page